Artículo

La versión final de este artículo es de uso interno de la institución.
Consulte el artículo en la página del editor
Consulte la política de Acceso Abierto del editor

Abstract:

The purpose of this work is to review stability and activation properties of type 1 receptor, in order to explain the reasons for its extreme in vitro instability. We demonstrate that the treatment of rat kidney cytosol with H2O2 prevents aldosterone binding, DNA/steroid- receptor complex interactions, and prevents the receptor thermal inactivation. In contrast, exogenous sulfhydryl reducing reagents are necessary to insure maximum binding of mineralocorticoid receptor and DNA/steroid-receptor interaction. However, the presence of β- mercaptoethanol in thermal induced incubations reverts the H2O2 protection. We also demonstrate that contaminations with free or sequestered iron are harmful for both, receptor binding capacity (in a reversible form) and for hormone-receptor/DNA binding properties (in a partially reversible form). We propose a sulfhydryl oxidative mechanism for type I mineralocorticoid receptor inactivation in which iron contaminants might accelerate this process by oxidative catalysis. We also demonstrate that when thiol groups are blocked by specific reagents such as N-ethyl-maleimide or dithionitrobenzoic acid, type I sites loose binding capacity, but the protein is protected from oxidation as well as inactivation.

Registro:

Documento: Artículo
Título:Stability study on renal type I mineralocorticoid receptor
Autor:Galigniana, M.D.
Filiación:Departamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Buenos Aires (1428), Argentina
Palabras clave:mineralocorticoid receptor; oxidation; stability; thiol groups; 5,5' dithiobis(2 nitrobenzoic acid); aldosterone; DNA; edetic acid; egtazic acid; hydrogen peroxide; iron; mercaptoethanol; mineralocorticoid receptor; n ethylmaleimide; steroid; thiol group; animal cell; article; cell free system; cytosol; DNA binding; high temperature procedures; kidney; nonhuman; oxidation; rat; receptor binding; thermostability; Animalia
Año:1996
Volumen:59
Número:7
Página de inicio:511
Página de fin:521
DOI: http://dx.doi.org/10.1016/0024-3205(96)00331-1
Título revista:Life Sciences
Título revista abreviado:LIFE SCI.
ISSN:00243205
CODEN:LIFSA
CAS:5,5' dithiobis(2 nitrobenzoic acid), 69-78-3; aldosterone, 52-39-1, 6251-69-0; DNA, 9007-49-2; edetic acid, 150-43-6, 60-00-4; egtazic acid, 67-42-5; hydrogen peroxide, 7722-84-1; iron, 14093-02-8, 53858-86-9, 7439-89-6; mercaptoethanol, 60-24-2; n ethylmaleimide, 128-53-0
Registro:https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00243205_v59_n7_p511_Galigniana

Referencias:

  • Arriza, J., Weinberg, C., Cerelli, G., Glaser, T., Handelin, B., Housman, D., Evans, R., (1987) Science, 237, pp. 268-275
  • Patel, P., Sherman, T., Goldman, D., Watson, S., (1989) Mol. Endocrinol., 3, pp. 1877-1885
  • Ress, A., Bell, P., (1975) Biochem. Biophys. Acta, 411, pp. 121-132
  • Bodwell, J., Halbrook, N., Munck, A., (1984) Biochemistry, 23, pp. 4237-4242
  • Emadian, S., Luttge, W., Desmore, C., (1986) J. Steroid Biochem., 24, pp. 953-961
  • Galigniana, M., Vicent, G., Lantos, C., Burton, G., (1993) An.Asoc.Quim.Argent., pp. 81333-81340
  • Luttge, W., Gray, H., Densmore, C., (1984) J. Steroid Biochem., 20, pp. 545-553
  • Binart, N., Lomes, M., Rafestin-Oblin, M., E.baulieu, E., (1991) Proc. Natl. Acad. Sci., 88, pp. 10681-10685
  • Luttge, W., Emadian, S., (1988) Life Sci., 43, pp. 837-843
  • Falks, J., (1964) Porphyrins and Metalloporphvrins. BBA Library, 185-186, Elsevier Publishing Co., New York
  • Furhop, J., Smith, K., Laboratory Methods in Porphvrins and Metalloporphvrins Research. Elsevier Biomedical Press, 147-149, p. 1975. , New York
  • Teutsch, G., Costerousse, G., Deraet, R., Benzoni, J., Fortin, M., Philibert, D., (1981) Steroids, 38, pp. 651-655
  • Burton, G., Galigniana, M., Delavallaz, S., Brachet-Cota, A., Sproviero, A., Ghini, A., Lantos, C., (1995) Mol. Pharmacol., 47, pp. 535-543
  • Fraser, R., Lantos, C., (1978) J. Steroid Biochem., 9, pp. 273-276
  • Bradford, M., (1976) Analyt. Biochem., 72, pp. 248-256
  • Krozowski, Z., Funder, J., (1983) Proc. Natl. Acad. Sci., 80, pp. 6056-6060
  • Rafestin-Oblin, M., Michaud, A., (1977) J. Steroid Biochem., 8, pp. 19-23
  • Pratt, W., Ishii, D., (1972) Biochemistry, 11, pp. 1401-1410
  • Emadian, S., Luttge, W., (1988) J. Neurochem., 50, pp. 1456-1460
  • Ermacora, M., Fox, R., (1992) Proc. Natl. Acad. Sci., 89, pp. 6383-6387
  • Beeuwkes, R., Ichikawa, I., Brenner, B., (1981), The Kidney. B.Brenner and F.Rector (Eds.), 249-288, W.B.Saunders Co., Philadelphia; Bresnick, E., Sanchez, E., Pratt, W., (1988) J. Steroid Biochem., 30, pp. 267-269
  • Grillo, C., Vallee, S., Piroli, G., McEwen, B., De Nicola, A., (1992) J.Steroid Biochem. Molec. Biol., pp. 42515-42520
  • Ganesan, S., Bashirelahi, N., Young, J., Cohen, S., (1987) Life Sci., 41, pp. 2767-2776
  • Lemesle-Varloot, L., Ojasoo, T., Mornon, J., Raynaud, J., (1992) J. Steroid Biochem. Mol. Biol., 4, pp. 369-388
  • Hebbel, R., (1990) Semin. Hematol., 27, pp. 51-69
  • Berg, J., (1986) Science, 232, pp. 485-487
  • Stancato, L., Silverstein, A., Gitler, C., Groner, B., Pratt, W., (1996) J. Biol. Chem., 271, pp. 8831-8836
  • Abate, C., Patel, L., Rauscher, F., Currant, T., (1990) Science, 249, pp. 1157-1161
  • Grippo, J., Holmgren, A., Pratt, W., (1985) J. Biol. Chem., 260, pp. 93-97
  • Silva, C., Cidlowski, J., (1992) J. Steroid Biochem. Molec. Biol., 41, pp. 1-10

Citas:

---------- APA ----------
(1996) . Stability study on renal type I mineralocorticoid receptor. Life Sciences, 59(7), 511-521.
http://dx.doi.org/10.1016/0024-3205(96)00331-1
---------- CHICAGO ----------
Galigniana, M.D. "Stability study on renal type I mineralocorticoid receptor" . Life Sciences 59, no. 7 (1996) : 511-521.
http://dx.doi.org/10.1016/0024-3205(96)00331-1
---------- MLA ----------
Galigniana, M.D. "Stability study on renal type I mineralocorticoid receptor" . Life Sciences, vol. 59, no. 7, 1996, pp. 511-521.
http://dx.doi.org/10.1016/0024-3205(96)00331-1
---------- VANCOUVER ----------
Galigniana, M.D. Stability study on renal type I mineralocorticoid receptor. LIFE SCI. 1996;59(7):511-521.
http://dx.doi.org/10.1016/0024-3205(96)00331-1